Top MarketRank™ StocksTop MarketRank™NYSE:HUM Humana (HUM) Stock Price, News & Analysis $315.29 +3.49 (+1.12%) (As of 09/18/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Humana Stock (NYSE:HUM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Key Stats Today's Range$311.28▼$317.6350-Day Range$311.85▼$404.5252-Week Range$298.61▼$530.54Volume1.76 million shsAverage Volume1.64 million shsMarket Capitalization$37.99 billionP/E Ratio19.63Dividend Yield1.12%Price Target$398.70Consensus RatingHold Company OverviewHumana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.Read More… War on Elon Escalates… (Ad)Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.Click here to learn how you can benefit from its widespread distribution. Humana Stock Analysis - MarketRank™See Top Rated MarketRank™ StocksOverall MarketRank™: 100th PercentileHumana scored higher than 100% of companies evaluated by MarketBeat, and ranked 1st out of 1,015 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.2 / 5Analyst RatingHold Consensus RatingHumana has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on 9 buy ratings, 12 hold ratings, and no sell ratings.Amount of Analyst CoverageHumana has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Humana's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth23.06% Earnings GrowthEarnings for Humana are expected to grow by 23.06% in the coming year, from $16.00 to $19.69 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Humana is 19.63, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 134.09.Price to Earnings Ratio vs. SectorThe P/E ratio of Humana is 19.63, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 139.54.Price to Earnings Growth RatioHumana has a PEG Ratio of 2.56. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHumana has a P/B Ratio of 2.38. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Humana's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.76% of the float of Humana has been sold short.Short Interest Ratio / Days to CoverHumana has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Humana has recently decreased by 6.22%, indicating that investor sentiment is improving significantly. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldHumana pays a meaningful dividend of 1.09%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthHumana does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Humana is 22.04%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Humana will have a dividend payout ratio of 17.98% next year. This indicates that Humana will be able to sustain or increase its dividend.Read more about Humana's dividend. Sustainability and ESG3.9 / 5Environmental Score-0.75 Percentage of Shares Shorted1.76% of the float of Humana has been sold short.Short Interest Ratio / Days to CoverHumana has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Humana has recently decreased by 6.22%, indicating that investor sentiment is improving significantly. News and Social Media1.5 / 5News Sentiment0.65 News SentimentHumana has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 16 news articles for Humana this week, compared to 19 articles on an average week.Search InterestOnly 24 people have searched for HUM on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Humana to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Humana insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.32% of the stock of Humana is held by insiders.Percentage Held by Institutions92.38% of the stock of Humana is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Humana's insider trading history. HUM Stock News HeadlinesVerint Systems' AI Bots Revolutionize Customer Service Efficiency (HUM)Verint's AI bots help automate customer service, cutting call times and improving efficiency, making it a key player in AI-driven customer experience solutions.September 11, 2024 | marketbeat.comHumana Foundation donates millions to Community Care CampusSeptember 18 at 5:36 PM | msn.comMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.September 18, 2024 | Paradigm Press (Ad)Humana to Cut Medicare Advantage Coverage in 13 Counties in 2025September 18 at 5:36 PM | msn.comHumana's Falling Share Price Gives Investors An OpportunitySeptember 18 at 7:31 AM | seekingalpha.comSoonerSelect patient says apparent birthdate mix-up leaving him without healthcareSeptember 17 at 10:23 AM | yahoo.comStocks on Sale Include Humana and ConagraSeptember 12, 2024 | msn.comHumana Unusual Options Activity For September 10September 12, 2024 | benzinga.comSee More Headlines HUM Stock Analysis - Frequently Asked Questions How have HUM shares performed this year? Humana's stock was trading at $457.81 at the beginning of the year. Since then, HUM shares have decreased by 31.1% and is now trading at $315.29. View the best growth stocks for 2024 here. How were Humana's earnings last quarter? Humana Inc. (NYSE:HUM) released its quarterly earnings data on Wednesday, July, 31st. The insurance provider reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.89 by $1.07. The business's quarterly revenue was up 10.4% on a year-over-year basis. Read the conference call transcript. Does Humana have any subsidiaries? Humana subsidiaries include these companies: Enclara Healthcare, Kindred Healthcare, American Eldercare, FPG, Metropolitan Health Networks, Certify Data Systems, Harris Rothenberg International, and more. Who are Humana's major shareholders? Top institutional investors of Humana include Pzena Investment Management LLC (1.92%), Davis Selected Advisers (1.92%), Marshall Wace LLP (1.18%) and Legal & General Group Plc (0.98%). Insiders that own company stock include Bruce D Broussard, David A Jr/Ky Jones, Samir Deshpande, Timothy S Huval, Joseph C Ventura, Susan M Diamond, Jorge S Mesquita and William Kevin Fleming. View institutional ownership trends. How do I buy shares of Humana? Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Humana own? Based on aggregate information from My MarketBeat watchlists, some other companies that Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Walt Disney (DIS), Visa (V), Mastercard (MA), Alibaba Group (BABA) and Boeing (BA). Company Calendar Ex-Dividend for 7/26 Dividend6/28/2024Dividend Payable7/26/2024Last Earnings7/31/2024Today9/18/2024Ex-Dividend for 10/25 Dividend9/30/2024Dividend Payable10/25/2024Next Earnings (Estimated)11/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Hospital & medical service plans Sub-IndustryManaged Health Care Current SymbolNYSE:HUM CUSIP44485910 CIK49071 Webwww.humana.com Phone(502) 580-1000Fax502-580-3639Employees67,600Year Founded1961Price Target and Rating Average Stock Price Target$398.70 High Stock Price Target$579.00 Low Stock Price Target$310.00 Potential Upside/Downside+26.5%Consensus RatingHold Rating Score (0-4)2.43 Research Coverage21 Analysts Profitability EPS (Most Recent Fiscal Year)$16.06 Trailing P/E Ratio19.63 Forward P/E Ratio19.71 P/E Growth2.56Net Income$2.49 billion Net Margins1.53% Pretax Margin2.18% Return on Equity16.12% Return on Assets5.26% Debt Debt-to-Equity Ratio0.70 Current Ratio1.66 Quick Ratio1.66 Sales & Book Value Annual Sales$112.04 billion Price / Sales0.34 Cash Flow$32.91 per share Price / Cash Flow9.58 Book Value$132.55 per share Price / Book2.38Miscellaneous Outstanding Shares120,501,000Free Float120,115,000Market Cap$37.99 billion OptionableOptionable Beta0.50 Social Links Should I Buy Humana Stock? HUM Pros and Cons Explained These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, August 27, 2024. Please send any questions or comments about these Humana pros and cons to contact@marketbeat.com. Humana Bull Case Here are some ways that investors could benefit from investing in Humana Inc.: Humana Inc. stock price is currently at $358.55, showing a positive trend in recent trading. Analysts have set a consensus price target of $396.35, indicating potential for growth. Fifth Third Bancorp increased its holdings in Humana by 41.7% in the second quarter, reflecting confidence in the company. Recent analyst reports have upgraded Humana to "hold" and "buy" ratings, suggesting positive sentiment. Institutional investors and hedge funds continue to show interest in Humana, with significant stakes in the company. Humana Bear Case Investors should be bearish about investing in Humana Inc. for these reasons: Humana's P/E ratio of 22.33 may indicate the stock is currently overvalued. The company's beta of 0.51 suggests lower volatility compared to the market average, potentially limiting short-term gains. While some analysts have upgraded Humana, others have maintained a "neutral" rating, indicating mixed opinions on the stock. Debt-to-equity ratio of 0.70 may raise concerns about the company's financial leverage. Despite recent positive movements, Humana's stock has faced resistance at certain price levels, signaling potential challenges ahead. This page (NYSE:HUM) was last updated on 9/18/2024 by MarketBeat.com Staff From Our PartnersChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Humana Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Humana With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.